Your medical briefing
Research, guidelines, and safety alerts for your specialty.
Recent updates in Psychiatry from the last 30 days.
Teva Pharmaceuticals USA has issued a Class II recall of traZODone Hydrochloride Tablets, USP, 50 mg (100-tablet bottles, NDC 50111-560-01), manufactured in Croatia by Pliva Hrvatska for Teva. The recall was initiated due to the presence of foreign tablets or capsules within the affected product.
Apotex Corp. issued a Class II recall for Paxil CR (paroxetine) extended-release tablets, 37.5mg, 30-count bottles, NDC 60505-4379-3. The recall notice states the product failed dissolution specifications and did not meet 24-month stability testing acceptance criteria.
